Company · CIK 0001626971 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Corvus Pharmaceuticals, Inc. · CRVS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 PForm 4 → | Jun 15, 5:12 pm EDT | David Scott MooreDirector | 21,700 | $11.53 | $250,236 | 21,700 | — | |
| Dec 27, 2018 PForm 4 → | Dec 31, 4:16 pm EST | Richard A Miller M.D.President and CEO, Director | 20,000 | $3.29 | $65,884 | 1,128,795 | +1.80% | plan? |
| Dec 21, 2018 PForm 4 → | Dec 27, 4:08 pm EST | Leiv LeaChief Financial Officer | 24,700 | $4.15 | $102,409 | 24,700 | — | plan? late |
| Dec 20, 2018 PForm 4 → | Dec 26, 4:05 pm EST | Richard A Miller M.D.President and CEO, Director | 10,000 | $4.40 | $43,950 | 1,108,795 | +0.91% | plan? late |
| Dec 11, 2018 GForm 4 → | Dec 14, 4:07 pm EST | Richard A Miller M.D.President and CEO, Director | 20,000 | — | — | 1,098,795 | — | plan? late |
| Dec 6, 2018 PForm 4 → | Dec 10, 4:05 pm EST | Richard A Miller M.D.President and CEO, Director | 5,000 | $5.99 | $29,934 | 1,118,795 | +0.45% | plan? |
| Dec 4, 2018 PForm 4 → | Dec 6, 4:06 pm EST | Richard A Miller M.D.President and CEO, Director | 1,502 | $5.95 | $8,937 | 1,113,795 | +0.14% | plan? |
| Mar 12, 2018 PForm 4 → | Mar 14, 2:05 pm EDT | Peter A. ThompsonDirector, 10% Owner | 588,235 | $8.50 | $4,999,998 | 5,967,584 | +10.9% | plan? |
| Mar 12, 2018 PForm 4 → | Mar 14, 1:58 pm EDT | ORBIMED ADVISORS LLC +1Director, 10% Owner | 588,235 | $8.50 | $4,999,998 | 5,967,584 | +10.9% | plan? |
| Mar 12, 2018 PForm 4 → | Mar 13, 5:12 pm EDT | Novo Holdings A/S10% Owner | 1,176,470 | $8.50 | $9,999,995 | 4,420,516 | +36.3% | plan? |
| Mar 12, 2018 PForm 4 → | Mar 13, 4:07 pm EDT | Terry P GouldDirector, 10% Owner | 588,235 | $8.50 | $4,999,998 | 126,806 | — | plan? |
| Mar 12, 2018 PForm 4 → | Mar 13, 3:30 pm EDT | ADAMS STREET PARTNERS LLC10% Owner | 588,235 | $8.50 | $4,999,998 | 126,806 | — | plan? |
| Mar 12, 2018 PForm 4 → | Mar 12, 4:05 pm EDT | Richard A Miller M.D.President and CEO, Director | 100,000 | $8.50 | $850,000 | 1,112,293 | +9.88% | plan? |
| Nov 20, 2017 PForm 4 → | Nov 22, 4:06 pm EST | Richard A Miller M.D.President and CEO, Director | 10,000 | $10.79 | $107,850 | 1,012,293 | +1.00% | plan? |
| Jun 23, 2017 PForm 4 → | Jun 27, 4:52 pm EDT | Novo Holdings A/S10% Owner | 20,000 | $10.95 | $219,000 | 3,244,046 | +0.62% | plan? |
| Jun 9, 2017 PForm 4 → | Jun 13, 4:06 pm EDT | Richard A Miller M.D.President and CEO, Director | 25,000 | $9.88 | $247,084 | 1,002,293 | +2.56% | plan? |
| Oct 28, 2016 GForm 5 → | Feb 10, 2017, 4:17 pm EST | Richard A Miller M.D.President and CEO, Director | 100,000 | — | — | 977,293 | — | plan? |
| Aug 25, 2016 GForm 5 → | Feb 10, 2017, 4:18 pm EST | Leiv LeaChief Financial Officer | 50,047 | — | — | 149,206 | — | plan? |
| Jun 23, 2016 PForm 4 → | Jun 27, 6:51 pm EDT | Peter A. ThompsonDirector, 10% Owner | 1,000 | $12.98 | $12,983 | 5,379,349 | +0.02% | plan? |
| Jun 23, 2016 PForm 4 → | Jun 27, 6:47 pm EDT | ORBIMED ADVISORS LLC +2Director, 10% Owner | 1,000 | $12.98 | $12,983 | 5,379,349 | +0.02% | plan? |
| Jun 17, 2016 PForm 4 → | Jun 21, 7:00 pm EDT | Peter A. ThompsonDirector, 10% Owner | 38,383 | $12.75 | $489,192 | 5,378,349 | +0.72% | plan? |
| Jun 17, 2016 PForm 4 → | Jun 21, 6:55 pm EDT | ORBIMED ADVISORS LLC +2Director, 10% Owner | 38,383 | $12.75 | $489,192 | 5,378,349 | +0.72% | plan? |
| Jun 14, 2016 PForm 4 → | Jun 16, 6:05 pm EDT | Peter A. ThompsonDirector, 10% Owner | 20,000 | $12.35 | $247,000 | 5,339,966 | +0.38% | plan? |
| Jun 14, 2016 PForm 4 → | Jun 16, 5:59 pm EDT | ORBIMED ADVISORS LLC +2Director, 10% Owner | 20,000 | $12.35 | $247,000 | 5,339,966 | +0.38% | plan? |
| Jun 9, 2016 PForm 4 → | Jun 13, 5:23 pm EDT | Peter A. ThompsonDirector, 10% Owner | 50,000 | $12.96 | $648,100 | 5,319,966 | +0.95% | plan? |
| Jun 9, 2016 PForm 4 → | Jun 13, 5:18 pm EDT | ORBIMED ADVISORS LLC +2Director, 10% Owner | 50,000 | $12.96 | $648,100 | 5,319,966 | +0.95% | plan? |
| May 20, 2016 PForm 4 → | May 24, 4:48 pm EDT | Peter A. ThompsonDirector, 10% Owner | 4,716 | $13.09 | $61,732 | 5,269,966 | +0.09% | plan? |
| May 20, 2016 PForm 4 → | May 24, 4:37 pm EDT | ORBIMED ADVISORS LLC +2Director, 10% Owner | 4,716 | $13.09 | $61,732 | 5,269,966 | +0.09% | plan? |
| May 18, 2016 PForm 4 → | May 20, 5:21 pm EDT | ORBIMED ADVISORS LLC +2Director | 6,800 | $11.77 | $80,035 | 5,265,250 | +0.13% | plan? |
| May 18, 2016 PForm 4 → | May 20, 4:27 pm EDT | Peter A. ThompsonDirector, 10% Owner | 6,800 | $11.77 | $80,035 | 5,265,250 | +0.13% | plan? |
| May 12, 2016 PForm 4 → | May 16, 6:38 pm EDT | Richard A Miller M.D.President and CEO, Director | 30,300 | $10.00 | $302,981 | 1,077,293 | +2.89% | plan? |
| May 12, 2016 PForm 4 → | May 16, 5:01 pm EDT | A/S Novo10% Owner | 70,000 | $10.00 | $700,000 | 3,224,046 | +2.22% | plan? |
| Mar 29, 2016 PForm 4 → | Mar 30, 1:07 pm EDT | A/S Novo10% Owner | 666,666 | $15.00 | $9,999,990 | 3,154,046 | +26.8% | plan? |
| Mar 29, 2016 CForm 4 → | Mar 30, 1:07 pm EDT | A/S Novo10% Owner | 2,487,380 | — | — | 2,487,380 | — | plan? |
| Mar 29, 2016 PForm 4 → | Mar 29, 12:21 pm EDT | ORBIMED ADVISORS LLCDirector, 10% Owner | 550,000 | $15.00 | $8,250,000 | 5,258,450 | +11.7% | plan? |
| Mar 29, 2016 CForm 4 → | Mar 29, 12:21 pm EDT | ORBIMED ADVISORS LLCDirector, 10% Owner | 4,708,450 | — | — | 4,708,450 | — | plan? |
| Mar 29, 2016 PForm 4 → | Mar 29, 12:00 pm EDT | Peter A. ThompsonDirector, 10% Owner | 550,000 | $15.00 | $8,250,000 | 5,258,450 | +11.7% | plan? |
| Mar 29, 2016 CForm 4 → | Mar 29, 12:00 pm EDT | Peter A. ThompsonDirector, 10% Owner | 4,708,450 | — | — | 4,708,450 | — | plan? |
| Mar 29, 2016 PForm 4 → | Mar 29, 11:54 am EDT | ADAMS STREET PARTNERS LLC10% Owner | 200,000 | $15.00 | $3,000,000 | 736,033 | +37.3% | plan? |
| Mar 29, 2016 CForm 4 → | Mar 29, 11:54 am EDT | ADAMS STREET PARTNERS LLC10% Owner | 2,487,381 | — | — | 681,256 | — | plan? |
| Mar 29, 2016 CForm 4 → | Mar 29, 11:48 am EDT | Richard A Miller M.D.President and CEO, Director | 328,765 | — | — | 1,046,993 | — | plan? |
| Mar 29, 2016 CForm 4 → | Mar 29, 11:42 am EDT | Leiv LeaChief Financial Officer | 42,608 | — | — | 199,253 | — | plan? |
| Mar 29, 2016 PForm 4 → | Mar 29, 11:39 am EDT | Terry P GouldDirector, 10% Owner | 200,000 | $15.00 | $3,000,000 | 736,033 | +37.3% | plan? |
| Mar 29, 2016 CForm 4 → | Mar 29, 11:39 am EDT | Terry P GouldDirector, 10% Owner | 2,487,381 | — | — | 681,256 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 AForm 4 → | Jun 15, 5:12 pm EDT | David Scott MooreDirector | 15,000 | — | — | 15,000 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:10 pm EDT | Ian T ClarkDirector | 15,000 | — | — | 15,000 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:08 pm EDT | Linda GraisDirector | 15,000 | — | — | 15,000 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:06 pm EDT | Peter A. ThompsonDirector, 10% Owner | 15,000 | — | — | 15,000 | — | |
| Jun 11, 2026 AForm 4 → | Jun 15, 5:04 pm EDT | Richard van den BroekDirector | 15,000 | — | — | 15,000 | — | |
| Jan 28, 2019 AForm 4 → | Jan 30, 4:08 pm EST | Linda S GraisDirector | 30,000 | — | — | 30,000 | — | |
| Jan 28, 2019 AForm 4 → | Jan 30, 4:07 pm EST | Mehrdad MobasherChief Medical Officer | 210,000 | — | — | 210,000 | — | |
| Dec 12, 2018 AForm 4 → | Dec 14, 4:09 pm EST | William Benton JonesSee Remarks | 100,000 | — | — | 100,000 | — | |
| Dec 12, 2018 AForm 4 → | Dec 14, 4:07 pm EST | Richard A Miller M.D.President and CEO, Director | 250,000 | — | — | 250,000 | — | |
| Dec 12, 2018 AForm 4 → | Dec 14, 4:06 pm EST | Joseph J BuggyEVP Discovery Research | 100,000 | — | — | 100,000 | — | |
| Dec 12, 2018 AForm 4 → | Dec 14, 4:06 pm EST | Leiv LeaChief Financial Officer | 100,000 | — | — | 100,000 | — | |
| Dec 12, 2018 AForm 4 → | Dec 14, 4:05 pm EST | Daniel W. HuntSVP, Chief Business Officer | 50,000 | — | — | 50,000 | — | |
| Dec 12, 2018 AForm 4 → | Dec 14, 4:05 pm EST | Erik J. VernerV.P., Chemistry Research | 50,000 | — | — | 50,000 | — | |
| Jun 21, 2018 AForm 4 → | Jun 25, 4:15 pm EDT | ADAMS STREET PARTNERS LLC10% Owner | 15,000 | — | — | 15,000 | — | |
| Jun 21, 2018 AForm 4 → | Jun 25, 4:06 pm EDT | Peter A. ThompsonDirector, 10% Owner | 15,000 | — | — | 15,000 | — | |
| Jun 21, 2018 AForm 4 → | Jun 25, 4:05 pm EDT | Scott W MorrisonDirector | 15,000 | — | — | 15,000 | — | |
| Jun 21, 2018 AForm 4 → | Jun 25, 4:05 pm EDT | Terry P GouldDirector, 10% Owner | 15,000 | — | — | 15,000 | — | |
| Jun 21, 2018 AForm 4 → | Jun 25, 4:05 pm EDT | Ian T ClarkDirector | 15,000 | — | — | 15,000 | — | |
| Jun 21, 2018 AForm 4 → | Jun 25, 4:05 pm EDT | Steve E. KrognesDirector | 15,000 | — | — | 15,000 | — | |
| Jan 19, 2018 AForm 4 → | Jan 23, 4:06 pm EST | Joseph J BuggyEVP Discovery Research | 100,000 | — | — | 100,000 | — | |
| Dec 13, 2017 AForm 4 → | Dec 15, 4:13 pm EST | Erik J. VernerV.P., Chemistry Research | 25,000 | — | — | 25,000 | — | |
| Dec 13, 2017 AForm 4 → | Dec 15, 4:10 pm EST | William Benton JonesSee Remarks | 40,000 | — | — | 40,000 | — | |
| Dec 13, 2017 AForm 4 → | Dec 15, 4:09 pm EST | Daniel W. HuntSVP, Chief Business Officer | 200,000 | — | — | 200,000 | — | |
| Dec 13, 2017 AForm 4 → | Dec 15, 4:08 pm EST | Leiv LeaChief Financial Officer | 40,000 | — | — | 40,000 | — | |
| Dec 13, 2017 AForm 4 → | Dec 15, 4:06 pm EST | Richard A Miller M.D.President and CEO, Director | 125,000 | — | — | 125,000 | — | |
| Jun 8, 2017 AForm 4 → | Jun 9, 4:06 pm EDT | Terry P GouldDirector, 10% Owner | 15,000 | — | — | 15,000 | — | |
| Jun 8, 2017 AForm 4 → | Jun 9, 4:06 pm EDT | Peter A. ThompsonDirector, 10% Owner | 15,000 | — | — | 15,000 | — | |
| Jun 8, 2017 AForm 4 → | Jun 9, 4:05 pm EDT | Steve E. KrognesDirector | 15,000 | — | — | 15,000 | — | |
| Jun 8, 2017 AForm 4 → | Jun 9, 4:05 pm EDT | Ian T ClarkDirector | 15,000 | — | — | 15,000 | — | |
| Jun 8, 2017 AForm 4 → | Jun 9, 4:05 pm EDT | Scott W MorrisonDirector | 15,000 | — | — | 15,000 | — | |
| Jun 8, 2017 AForm 4 → | Jun 9, 4:01 pm EDT | ADAMS STREET PARTNERS LLC10% Owner | 15,000 | — | — | 15,000 | — | |
| Jan 3, 2017 AForm 4 → | Jan 4, 4:06 pm EST | Ian T ClarkDirector | 30,000 | — | — | 30,000 | — | |
| Dec 7, 2016 AForm 4 → | Dec 8, 7:07 pm EST | Richard A Miller M.D.President and CEO, Director | 160,000 | — | — | 160,000 | — | |
| Dec 7, 2016 AForm 4 → | Dec 8, 7:06 pm EST | Erik J. VernerV.P., Chemistry Research | 25,000 | — | — | 25,000 | — | |
| Dec 7, 2016 AForm 4 → | Dec 8, 7:05 pm EST | William Benton JonesVP Pharmaceutical Development | 25,000 | — | — | 25,000 | — | |
| Dec 7, 2016 AForm 4 → | Dec 8, 7:03 pm EST | Leiv LeaChief Financial Officer | 25,000 | — | — | 25,000 | — | |
| Jun 8, 2016 AForm 4 → | Jun 10, 4:06 pm EDT | Jason V ColomaSVP, Chief Business Officer | 200,000 | — | — | 200,000 | — | |
| Mar 29, 2016 CForm 4 → | Mar 30, 1:07 pm EDT | A/S Novo10% Owner | 2,487,380 | — | — | 0 | — | |
| Mar 29, 2016 CForm 4 → | Mar 29, 12:21 pm EDT | ORBIMED ADVISORS LLCDirector, 10% Owner | 4,708,450 | — | — | 0 | — | |
| Mar 29, 2016 CForm 4 → | Mar 29, 12:00 pm EDT | Peter A. ThompsonDirector, 10% Owner | 4,708,450 | — | — | 0 | — | |
| Mar 29, 2016 CForm 4 → | Mar 29, 11:54 am EDT | ADAMS STREET PARTNERS LLC10% Owner | 2,487,381 | — | — | 0 | — | |
| Mar 29, 2016 CForm 4 → | Mar 29, 11:48 am EDT | Richard A Miller M.D.President and CEO, Director | 328,765 | — | — | 0 | — | |
| Mar 29, 2016 CForm 4 → | Mar 29, 11:42 am EDT | Leiv LeaChief Financial Officer | 42,608 | — | — | 0 | — | |
| Mar 29, 2016 CForm 4 → | Mar 29, 11:39 am EDT | Terry P GouldDirector, 10% Owner | 2,487,381 | — | — | 0 | — | |
| Mar 22, 2016 AForm 4 → | Mar 24, 4:07 pm EDT | William Benton JonesVP Pharmaceutical Development | 60,000 | — | — | 60,000 | — | |
| Mar 22, 2016 AForm 4 → | Mar 24, 4:06 pm EDT | Steve E. KrognesDirector, 10% Owner | 30,000 | — | — | 30,000 | — | |
| Mar 22, 2016 AForm 4 → | Mar 24, 4:05 pm EDT | Richard A Miller M.D.President and CEO, Director | 500,000 | — | — | 500,000 | — | |
| Mar 22, 2016 AForm 4 → | Mar 24, 4:04 pm EDT | Peter A. ThompsonDirector, 10% Owner | 30,000 | — | — | 30,000 | — | |
| Mar 22, 2016 AForm 4 → | Mar 24, 4:04 pm EDT | Leiv LeaChief Financial Officer | 60,000 | — | — | 60,000 | — | |
| Mar 22, 2016 AForm 4 → | Mar 24, 4:03 pm EDT | Erik J. VernerV.P., Chemistry Research | 60,000 | — | — | 60,000 | — | |
| Mar 22, 2016 AForm 4 → | Mar 24, 4:02 pm EDT | Terry P GouldDirector, 10% Owner | 30,000 | — | — | 30,000 | — | |
| Mar 22, 2016 AForm 4 → | Mar 24, 4:01 pm EDT | ADAMS STREET PARTNERS LLC10% Owner | 30,000 | — | — | 30,000 | — |